The Next “Big Thing” There are a plethora of issues that are changing the economic face of medical product development. From globalization to personalized medicine, from mergers to orphan drugs, these issues are challenging the status quo and forcing companies to reexamine their business models and develop innovative approaches to product development to remain relevant. To prepare for this Discussion, consider the following statement: Historically, large pharmaceutical companies led the medical products market with a model of developing “blockbuster” drugs. Some industry analysts now believe that much of the future market growth in drug development will come from small biotech start-up companies. By Day 4, post a comprehensive response to the following: Do you believe that this will be the case? Why or why not? Cite an example. What are some potential implications for innovation that this trend might have on the flow of new products into the global market? Please give a example.
